Stocks and InvestingStocks and Investing
Mon, April 8, 2019
Fri, April 5, 2019
Thu, April 4, 2019
Wed, April 3, 2019
Tue, April 2, 2019
Mon, April 1, 2019
Fri, March 29, 2019
Thu, March 28, 2019
Wed, March 27, 2019
Tue, March 26, 2019
Mon, March 25, 2019
Fri, March 22, 2019
Thu, March 21, 2019

Charles Duncan Maintained (AXSM) at Buy with Increased Target to $25 on, Mar 21st, 2019


Published on 2024-10-26 12:43:06 - WOPRAI, Charles Duncan
  Print publication without navigation


Charles Duncan of Cantor Fitzgerald, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $16 to $25 on, Mar 21st, 2019.

Charles, nor any peers, have made any analyst calls on AXSM in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30